Cystic fibrosis secondary prevention: Difference between revisions
Jump to navigation
Jump to search
| Line 11: | Line 11: | ||
==Secondary Prevention== | ==Secondary Prevention== | ||
*The prevention of airway infection with resistant bacterial pathogens (especially ''P. aeruginosa'') is essential. | *The prevention of airway infection with resistant bacterial pathogens (especially ''P. aeruginosa'') is essential.<ref name="pmid29303286">{{cite journal |vauthors=Fila L |title=[Cystic fibrosis in adults] |language=Czech |journal=Vnitr Lek |volume=63 |issue=11 |pages=834–842 |date= 2018 |pmid=29303286 |doi= |url=}}</ref> | ||
==References== | ==References== | ||
Revision as of 20:54, 22 February 2018
|
Cystic fibrosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Cystic fibrosis secondary prevention On the Web |
|
American Roentgen Ray Society Images of Cystic fibrosis secondary prevention |
|
Risk calculators and risk factors for Cystic fibrosis secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shaghayegh Habibi, M.D.[2]
Overview
There are no established measures for the secondary prevention of [disease name].
OR
Effective measures for the secondary prevention of [disease name] include [strategy 1], [strategy 2], and [strategy 3].
Secondary Prevention
- The prevention of airway infection with resistant bacterial pathogens (especially P. aeruginosa) is essential.[1]